![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
ASCO 2015: Latest in chronic lymphocytic leukaemia (ecancer) View |
![]() |
2015 ASCO Annual Meeting Highlights (OncLive) View |
![]() |
ASCO 2015: New Ibrutinib Combination Regimen Shows Substantial Benefits in Relapsed CLL (EMJ) View |
![]() |
What Was Hot in Hematology at ASCO 2015 (American Society of Hematology) View |
![]() |
Progress in the treatment of chronic lymphocytic leukaemia (EMJ) View |
![]() |
Ibrutinib combination regimen shows substantial benefits in relapsed chronic lymphocytic leukaemia (ecancer) View |
![]() |
A review of current and future directions of clinical trials for CLL (VJHemOnc – Video Journal of Hematology \u0026 HemOnc) View |
![]() |
Understanding ultra high-risk CLL and advances with ibrutinib therapy (VJHemOnc – Video Journal of Hematology \u0026 HemOnc) View |
![]() |
Treatment options for the young CLL patient with deletion 17p: Do they need a different approach (HMP Education) View |
![]() |
Optimal Combination and Sequence of Chronic Lymphocytic Leukemia Therapies (OncLive) View |